midodrine has been researched along with Fatigue Syndrome, Chronic in 3 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The diagnosis of chronic fatigue syndrome (CFS) is based on patient history and treatment on cognitive behavior therapy and graded exercise." | 1.32 | Dysautonomia in chronic fatigue syndrome: facts, hypotheses, implications. ( Naschitz, JE; Rosner, I; Yeshurun, D, 2004) |
| "Midodrine treatment, directed at the autonomic nervous system, resulted in correction of the dysautonomia followed by improvement of fatigue." | 1.32 | Midodrine treatment for chronic fatigue syndrome. ( Dreyfuss, D; Naschitz, J; Rosner, I; Yeshurun, D, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Newton, JL | 1 |
| Sheth, A | 1 |
| Shin, J | 1 |
| Pairman, J | 1 |
| Wilton, K | 1 |
| Burt, JA | 1 |
| Jones, DE | 1 |
| Naschitz, JE | 1 |
| Yeshurun, D | 2 |
| Rosner, I | 2 |
| Naschitz, J | 1 |
| Dreyfuss, D | 1 |
1 trial available for midodrine and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Lower ambulatory blood pressure in chronic fatigue syndrome.
Topics: Blood Pressure Monitoring, Ambulatory; Fatigue Syndrome, Chronic; Female; Heart Rate; Humans; Hypote | 2009 |
2 other studies available for midodrine and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Dysautonomia in chronic fatigue syndrome: facts, hypotheses, implications.
Topics: Arrhythmias, Cardiac; Autonomic Nervous System Diseases; Diagnosis, Differential; Evidence-Based Med | 2004 |
Midodrine treatment for chronic fatigue syndrome.
Topics: Adult; Fatigue Syndrome, Chronic; Humans; Male; Midodrine; Sympathomimetics | 2004 |